Trials / Completed
CompletedNCT03085303
Treatment of Atopic Dermatitis by a Full-Body Blue Light Device
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- Philips Electronics Nederland BV · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Multicentric, placebo-controlled, double-blinded, three-armed, prospective, randomized controlled trial.150 patients diagnosed with atopic dermatitis will be randomized to arm 1 (irradiation for 30min at 415nm wavelength), arm 2 (irradiation for 30min at 450nm wavelength), and arm 3 (irradiation for 30min at low-dose (placebo)). Irradiation will be scheduled 3 times a week for 8 weeks. Patients will be followed up for four weeks after the last irradiation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Full Body Blue Light Device | Full body blue light irradiation (phototherapy) of atopic dermatitis patients. |
Timeline
- Start date
- 2017-03-16
- Primary completion
- 2018-07-31
- Completion
- 2018-07-31
- First posted
- 2017-03-21
- Last updated
- 2018-08-07
Locations
3 sites across 2 countries: Germany, Switzerland
Source: ClinicalTrials.gov record NCT03085303. Inclusion in this directory is not an endorsement.